However, the presence of P-gp in other cells of the human body, other than tumor cells, makes this inhibition strategy problematic because chemical inhibitors do not discriminate P-gp expressed in normal tissues of the body from that found in tumor tissues, leading to the accumulation of several toxic xenobiotics and endobiotics in different tissues of the human body [19,142]. Here, PGP is linked to neoplasm.